there were statistically significant decreases (improvement) in size and severity of perfusion abnormalities by rest-dipyridamole pet on comparison of baseline control with perfusion abnormalities after intensive 90-day cholesterol lowering and significant increases (worsening) in size and severity after the final control period, respectively, as follows.